Literature DB >> 2430811

Modulation of surface T11 molecules induced by monoclonal antibodies: analysis of the functional relationship between antigen-dependent and antigen-independent pathways of human T cell activation.

A Moretta, D Olive, A Poggi, G Pantaleo, C Mawas, L Moretta.   

Abstract

Previous data indicated that T lymphocyte activation can be achieved by using a combination of anti-T11 monoclonal antibodies (mAb) directed to the "T11(2)" and the "T11(3)" epitopes, respectively. Unlike the T cell activation induced by antibodies directed to the T3-T cell receptor (Ti) complex or to T44 molecules, the anti-T11 mAb-induced cell activation was not accompanied by surface modulation of the T11 antigen. In the present study we show that appropriate stimulatory combinations of anti-T11 mAb are able to induce T11 antigen modulation in a variety of T cells including polyclonal peripheral blood populations, normal as well as leukemic (JA3) T cell clones. The first anti-T11 mAb combination leading to both cell activation and T11 antigen modulation was given by a mAb directed to the T11(2) epitope and by another mAb recognizing an epitope belonging to the T11(1) group. The second combination was given by two mAb directed against two different determinants of the T11(1) group. The ability to induce T11 antigen modulation allowed a more precise analysis of the pathway of T cell activation initiated by T11 molecules and its physical and functional relationship with the other known pathways of T cell activation. T cells following T11 antigen modulation failed to respond to subsequent stimulation with anti-T11 mAb. The refractory period lasted for 48-72 h and the restoration of the responsiveness to anti-T11 mAb coincided with the re-expression of T11 molecules at the cell surface. Modulation of T11 antigen did not affect the surface expression of T3, Ti or T44 molecules, in addition, "modulated" cells maintained their ability to respond to mAb directed against T3, Ti or T44 molecules. On the contrary, antibody-induced modulation of the T3-Ti receptor complex abrogated both T11- and T44-dependent T cell activation. Finally, antibody-induced modulation of T44 antigen did not inhibit either the T11- or the T3-Ti-dependent pathway of T cell activation. These data indicate that down-regulation of the pathway of T cell activation initiated by T11 molecules can be induced not only by modulation of the antigen receptor complex but also by appropriate mAb to T11 molecules and, presumably, by the natural ligand binding to T11 molecules.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430811     DOI: 10.1002/eji.1830161118

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Selection and characterization of T-cell variants lacking molecules involved in T-cell activation (T3 T-cell receptor, T44, and T11): analysis of the functional relationship among different pathways of activation.

Authors:  A Moretta; A Poggi; D Olive; C Bottino; C Fortis; G Pantaleo; L Moretta
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

2.  T-cell surface molecules involved in the induction and expression of lymphokine-activated killing of autologous and allogeneic tumor targets.

Authors:  A L Nashed; B Mukherji
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

3.  Studies on the monocyte dependence of T-cell proliferation induced by monoclonal antibodies directed against regions I and II of the CD2 antigen.

Authors:  R van Lier; E Bloemena; M Brouwer; J Van Heijst; S Weinreich; L Aarden
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

4.  Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation.

Authors:  G Pantaleo; D Olive; A Poggi; T Pozzan; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

5.  Inactivation of a T cell receptor-associated GTP-binding protein by antibody-induced modulation of the T cell receptor/CD3 complex.

Authors:  H Schrezenmeier; G Ahnert-Hilger; B Fleischer
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

6.  A novel integrin involved in thymocyte-thymic epithelial cell interactions.

Authors:  M Giunta; A Favre; D Ramarli; C E Grossi; G Corte
Journal:  J Exp Med       Date:  1991-06-01       Impact factor: 14.307

7.  CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.

Authors:  A Moretta; A Poggi; D Pende; G Tripodi; A M Orengo; N Pella; R Augugliaro; C Bottino; E Ciccone; L Moretta
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  Specific recognition of human CD3-CD16+ natural killer cells requires the expression of an autosomic recessive gene on target cells.

Authors:  E Ciccone; D Pende; O Viale; G Tambussi; S Ferrini; R Biassoni; A Longo; J Guardiola; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

Authors:  C Bottino; G Tambussi; S Ferrini; E Ciccone; P Varese; M C Mingari; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor.

Authors:  B E Bierer; A Peterson; J C Gorga; S H Herrmann; S J Burakoff
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.